Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 308

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

ENHANCEMENT OF EXPERIMENTAL FRACTURE-HEALING BY SYSTEMIC ADMINISTRATION OF RECOMBINANT HUMAN PARATHYROID HORMONE (PTH 1–34)

ALKHIARY, YASER M., GERSTENFELD, LOUIS C., KRALL, ELIZABETH, WESTMORE, MICHAEL, SATO, MASAHIKO, MITLAK, BRUCE H., EINHORN, THOMAS A.·2005·The Journal of Bone and Joint Surgery-American Volume

Abstract

BACKGROUND: Recombinant human parathyroid hormone (PTH [1-34]; teriparatide) is a new treatment for postmenopausal osteoporosis that can be systemically administered for the primary purpose of increasing bone formation. Because several studies have described the enhancement of fracture-healing and osteointegration in animals after use of PTH, we sought to critically analyze this skeletal effect. METHODS: Two hundred and seventy male Sprague-Dawley rats underwent standard, closed femoral fractures and were divided into three groups that were administered daily subcutaneous injections of 5 or 30 mug/kg of PTH (1-34) or vehicle (control). The dosing was administered for up to thirty-five days. Groups were further divided into three subgroups and were killed on day 21, 35, or 84 after the fracture. The bones were subjected to mechanical torsion testing, histomorphometric analysis, or microquantitative computed tomography. RESULTS: By day 21, calluses from the group treated with 30 mug of PTH showed significant increases over the controls with respect to torsional strength, stiffness, bone mineral content, bone mineral density, and cartilage volume. By day 35, both groups treated with PTH showed significant increases in bone mineral content and density and total osseous tissue volume, and they demonstrated significant decreases in void space and cartilage volume (p < 0.05). Torsional strength was significantly increased at this time-point in the group treated with 30 mug of PTH (p < 0.05). While dosing was discontinued on day 35, analyses performed after eighty-four days in the group treated with 30 mug of PTH showed sustained increases over the controls with respect to torsional strength and bone mineral density. No change was noted in osteoclast density at the time-points measured, suggesting that treatment with PTH enhanced bone formation but did not induce bone resorption. CONCLUSIONS: These data show that daily systemic administration of PTH (1-34) enhances fracture-healing by increasing bone mineral content and density and strength, and it produces a sustained anabolic effect throughout the remodeling phase of fracture-healing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2106/00004623-200504000-00006

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 308

Metadata

Authors
ALKHIARY, Y. M., GERSTENFELD, L. C., KRALL, E., WESTMORE, M., SATO, M., MITLAK, B. H., & EINHORN, T. A.
Venue
The Journal of Bone and Joint Surgery-American Volume
Published
2005-04
Volume
87
Issue
4
Pages
731-741
ISSN
0021-9355 (ISSN-L)
OpenAlex
W2054180787
Cited by
308
References
29
FWCI
14.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ENHANCEMENT OF EXPERIMENTAL FRACTURE-HEALING BY SYSTEMIC ADMINISTRATION OF RECOMBINANT HUMAN PARATHYROID HORMONE (PTH 1–34). https://app.cochat.ai/papers/10.2106/00004623-200504000-00006
The paper
ALKHIARY, Y. M., GERSTENFELD, L. C., KRALL, E., WESTMORE, M., SATO, M., MITLAK, B. H., & EINHORN, T. A. (2005). ENHANCEMENT OF EXPERIMENTAL FRACTURE-HEALING BY SYSTEMIC ADMINISTRATION OF RECOMBINANT HUMAN PARATHYROID HORMONE (PTH 1–34). The Journal of Bone and Joint Surgery-American Volume. https://doi.org/10.2106/00004623-200504000-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.